Midazolam-d<sub>4</sub> (maleate) (CRM)

Midazolam-d4 (maleate) (CRM)

CAT N°: 20199

Midazolam-d4 (maleate) (CRM) (Item No. 20199) is intended for use as an internal standard for the quantification of midazolam (Item Nos. 19391 | 16193) by GC- or LC-MS. Midazolam is used for sedation, to block seizures, and as an anticonvulsant antidote for organophosphate intoxication.{31896,31897,31898} This product is intended for research and forensic applications.

Territorial Availability: Available through Bertin Technologies only in France

Technical Warning: Bertin Technologies restricts the sale of this product to licensed controlled substance laboratories and qualified academic research institutions. Please contact us for further details.

Special Advice: Reference Materials RMs and Certified Reference Materials CRMs are dispatched directly to the end-user in accordance with ISO requirements. Please check regulation status before ordering; additionel fees can apply.

  • Synonyms
    • 8-chloro-6-(2-fluorophenyl-d4)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine maleate
  • Correlated keywords
    • 1435938-30-9 1435938-29-6 deuterated deuterium gasses chromatography liquid isotope GC-MS GC/MS LC-MS LC/MS LCMS GCMS anticonvulsant anti-convulsant antidote organophosphate anesthesia anti-seizure
  • Product Overview:
    Midazolam-d4 (maleate) (CRM) (Item No. 20199) is intended for use as an internal standard for the quantification of midazolam (Item Nos. 19391 | 16193) by GC- or LC-MS. Midazolam is used for sedation, to block seizures, and as an anticonvulsant antidote for organophosphate intoxication.{31896,31897,31898} This product is intended for research and forensic applications.

We also advise you